| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. van Koningsveld, van Doorn, Ang, and Van der Meché) and Statistics (Schmitz), Erasmus Medical Center Rotterdam, the Netherlands.
Address correspondence and reprint requests to Dr. R. van Koningsveld, Department of Neurology, Erasmus Medical Center Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands; e-mail: vankoningsveld{at}neuro.fgg.eur.nl
OBJECTIVE: Assessment of incidence rates of Guillain-Barré syndrome (GBS) in the Netherlands over a 10-year period; investigation of a relationship between possible seasonality in GBS and the occurrence of preceding infections; and determination of distinctive characteristics in patients with GBS who are only mildly affected (able to walk unaided at nadir).
METHOD: Records of patients with GBS admitted between 1987 and 1996 from all 45 hospitals in the southwest Netherlands were evaluated, covering a population of 4.2 million inhabitants.
RESULTS: A total of 476 patients met National Institute for Neurological and Communicative Disorders and Stroke criteria for GBS. This resulted in a crude incidence rate (IR) of 1.18/100,000 inhabitants. This IR increased linearly with age (p < 0.001). Men were more frequently affected than women (p < 0.001). No seasonal preponderance for GBS, nor for any of the preceding infections, was found. Patients under 50 years of age (p < 0.001) and men (p = 0.01) were more frequently found in the mildly affected group. In both groups a preceding infection was reported in 70% of the cases. In the severely affected group, serologic evidence for infection with Campylobacter jejuni, cytomegalovirus, Epstein–Barr virus, or Mycoplasma pneumoniae was found more frequently than in the mildly affected group (41% versus 16%, p = 0.001).
CONCLUSIONS: Overall IR in the Netherlands are similar to those found in other studies. The incidence increases linearly with age and men are more frequently affected than women. Distinctive characteristics for mildly and severely affected patients were found regarding age, sex, and preceding infections. This suggests that other infectious agents or host factors may be involved in mild forms of GBS.
Key words: Guillain-Barré syndrome—Epidemiology—Subgroups
This article has been cited by other articles:
|
|
 |
|
  H. C. Lehmann, G. Meyer zu Horste, B. C. Kieseier, and H.-P. Hartung Review: Pathogenesis and treatment of immune-mediated neuropathies Therapeutic Advances in Neurological Disorders, July 1, 2009; 2(4): 261 - 281. [Abstract] [PDF]
|
|
|
|
 |
|
 K Kuitwaard, R van Koningsveld, L Ruts, B C Jacobs, and P A van Doorn Recurrent Guillain-Barre syndrome J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 56 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L J Hauck, C White, T E Feasby, D W Zochodne, L W Svenson, and M D Hill Incidence of Guillain-Barre syndrome in Alberta, Canada: an administrative data study J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 318 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. C. Hughes, A. V. Swan, J.-C. Raphael, D. Annane, R. van Koningsveld, and P. A. van Doorn Immunotherapy for Guillain-Barre syndrome: a systematic review Brain, September 1, 2007; 130(9): 2245 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Geleijns, A. Roos, J. J. Houwing-Duistermaat, W. van Rijs, A. P. Tio-Gillen, J. D. Laman, P. A. van Doorn, and B. C. Jacobs Mannose-Binding Lectin Contributes to the Severity of Guillain-Barre Syndrome J. Immunol., September 15, 2006; 177(6): 4211 - 4217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hughes, J. Charlton, R. Latinovic, and M. C. Gulliford No association between immunization and guillain-barre syndrome in the United kingdom, 1992 to 2000. Arch Intern Med, June 26, 2006; 166(12): 1301 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Korinthenberg, J. Schessl, J. Kirschner, and J. S. Monting Intravenously Administered Immunoglobulin in the Treatment of Childhood Guillain-Barre Syndrome: A Randomized Trial Pediatrics, July 1, 2005; 116(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Geleijns, G. M.Th. Schreuder, B. C. Jacobs, K. Sintnicolaas, R. van Koningsveld, J. Meulstee, J. D. Laman, and P. A. van Doorn HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome Neurology, January 11, 2005; 64(1): 44 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, M. Koga, K. Yokoyama, and N. Yuki Epidemiology of Campylobacter jejuni Isolated from Patients with Guillain-Barre and Fisher Syndromes in Japan J. Clin. Microbiol., January 1, 2005; 43(1): 335 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Geleijns, B. A. Brouwer, B. C. Jacobs, J. J. Houwing-Duistermaat, C. M. van Duijn, and P. A. van Doorn The occurrence of Guillain-Barre syndrome within families Neurology, November 9, 2004; 63(9): 1747 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.A.C. Hughes, E.F.M. Wijdicks, R. Barohn, E. Benson, D.R. Cornblath, A. F. Hahn, J.M. Meythaler, R.G. Miller, J.T. Sladky, and J.C. Stevens Practice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, September 23, 2003; 61(6): 736 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hiraga, M. Mori, K. Ogawara, T. Hattori, and S. Kuwabara Differences in patterns of progression in demyelinating and axonal Guillain-Barre syndromes Neurology, August 26, 2003; 61(4): 471 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chio, D. Cocito, M. Leone, M.T. Giordana, G. Mora, R. Mutani, and the Piemonte and Valle d'Aosta Register for Guilla Guillain-Barre syndrome: A prospective, population-based incidence and outcome survey Neurology, April 8, 2003; 60(7): 1146 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Van Koningsveld, P.I.M. Schmitz, C.W. Ang, J. Groen, A.D.M.E. Osterhaus, F.G.A. Van der Meche, and P. A. Van Doorn Infections and course of disease in mild forms of Guillain-Barre syndrome Neurology, February 26, 2002; 58(4): 610 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Green and A. H. Ropper Mild Guillain-Barre Syndrome Arch Neurol, July 1, 2001; 58(7): 1098 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. van Koningsveld, R. Rico, I. Gerstenbluth, P.I.M. Schmitz, C. W. Ang, I. S.J. Merkies, B. C. Jacobs, Y. Halabi, H. P. Endtz, F. G.A. van der Meche, et al. Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean Island Curacao Neurology, June 12, 2001; 56(11): 1467 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Van Koningsveld, P.A. Van Doorn, P.I.M. Schmitz, and F.G.A. Van der Meche Changes in referral pattern and its effect on outcome in patients with Guillain-Barre syndrome Neurology, February 27, 2001; 56(4): 564 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Prendergast and A. P. Moran Review: Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies Innate Immunity, October 1, 2000; 6(5): 341 - 359. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
